ABDEL-LAB
ActiveABDEL-LAB has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €69k and a net result of €-12k. Equity is growing by ~15.3% per year across the filed fiscal years. Its solvency ranks better than 87% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
76
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability0▼-100
Solvency100=
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €5k at 30 days acceptable
Liquidity ample (current ratio 11.25 against 24.42 in 2024; short-term debt: 7.3% and cash: 79.8% of total assets), and 7.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
92.7%
Return on assets
-15.6%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-07-2026, 3 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
3 d early
2024
4 d early
2023
2 d late
2022
24 d late
2021
24 d late
2020
26 d late
2019
31 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Turnover
€108k
EBIT margin
-10.9%
Net result
€-12k
2024 · €22k
2018: €12k
2019: €26k
2020: €3k
2021: €11k
2022: €2k
2023: €6k
2024: €22k
2018 → 2025
Working capital
€56k▼ 9.7%
2024 · €63k
2018: €10k
2019: €37k
2020: €40k
2021: €52k
2022: €42k
2023: €52k
2024: €63k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€108k
Equity€52k-€54k▲ 3.4%€59k▲ 10.2%€81k▲ 36.7%€69k▼ 14.4%
Operating result€11k-€2k▼ 84.3%€6k▲ 214%€22k▲ 296%€-12k
Net result€11k-€2k▼ 84.3%€6k▲ 214%€22k▲ 296%€-12k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result turns negative in 2025: a loss of €12k after €22k in 2024, the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €75k
Fixed assets
€13k▼ 30.1%
Current assets
€62k▼ 5.0%
Equity and liabilities €75k
Equity
€69k▼ 14.4%
Debt
€6k▲ 106%
The debt ratio rises from 3.2% to 7.3%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€-6k▼
2024 · €27k
Cash flow
€-6k▼
2024 · €27k
Solvency
92.7%▼
2024 · 96.8%
Current ratio
11.25▼
2024 · 24.42
Quick ratio
11.25▼
2024 · 24.42
Debt / equity
0.08▲
2024 · 0.03
ROE
-16.8%▼
2024 · 26.9%
ROA
-15.6%▼
2024 · 26.0%
Debt
€6k▲
2024 · €3k
Debt ≤ 1 year
€6k▲
2024 · €3k
Staff costs
€14k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€84k€75k▼
Fixed assets21/28€19k€13k▼
Tangible fixed assets22/27€19k€13k▼
Furniture and vehicles24€19k€13k▼
Current assets29/58€65k€62k▼
Amounts receivable within one year40/41€8k€2k▼
Trade receivables40-€131
Other amounts receivable41€8k€2k▼
Cash at bank and in hand54/58€57k€60k▲
Equity and liabilities
Total equity and liabilities10/49€84k€75k▼
Equity10/15€81k€69k▼
Profit (loss) carried forward14€81k€69k▼
Amounts payable17/49€3k€6k▲
Amounts payable within one year42/48€3k€6k▲
Trade debts44€3k€4k▲
Suppliers440/4€3k€4k▲
Taxes, remuneration and social security45-€47
Remuneration and social security454/9-€47
Other amounts payable47/48-€1k
Income statement
Code20242025
Turnover70-€108k
Goods, raw materials, services and sundry goods60/61-€90k
Remuneration, social security and pensions62-€14k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5k€6k▲
Other operating charges640/8€103k€10k▼
Gross operating margin9900€129k€18k▼
Operating profit (loss)9901€22k€-12k▼
Profit (loss) for the period before taxes9903€22k€-12k▼
Profit (loss) for the period9904€22k€-12k▼
Profit (loss) for the period to be appropriated9905€22k€-12k▼
Appropriation of the result
Profit (loss) to be appropriated9906€81k€69k▼
Profit (loss) brought forward from the previous period14P€59k€81k▲
The notes to these accounts (3 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Weakest financial yearnet €-12k ▼154%
Net result drops to €-12k, the lowest in the series.
27-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
02-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 2 days late
2023
31-12
Financial
Liquidity triplescurrent ratio 15.96
Current ratio from 5.69 to 15.96; short-term debt falls from €9k to €4k.
24-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 24 days late
2022
24-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 24 days late
2021
26-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 26 days late
2020
31-12
Financial
Liquidity triplescurrent ratio 20.65
Current ratio from 7.86 to 20.65; short-term debt falls from €5k to €2k.
31-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 31 days late
2019
31-12
Financial
Highest result since 2018net €26k ▲115%
Operating result €26k, net result €26k, both a record.
31-12
Financial
Liquidity triplescurrent ratio 7.86
Current ratio from 3.11 to 7.86.
24-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ukkel · 1 establishment unit since 2018
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Achille Reisdorfflaan 271180 UkkelGround area
188 m²
Building footprint
65 m²
Volume, LiDAR
479 m³
Parcel 21616G0186/00A005, Brussels · tallest building 10.7 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
ABDEL-LAB
since 20182.325.382.582
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21616G0186/00A005 | Brussels | 188 m² | 1 · 65 m² | 10.7 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
MATSEN LIFE SCIENCES
BE 0782.905.509
Londerzeel · Eq €70k
Dokter Bert Hannosset
BE 0896.825.970
Leuven · Eq €68k
Baerts Analytica
BE 0704.638.187
Hove · Eq €72k
EP DESIGN
BE 0825.864.631
Bertem · Eq €66k
AJ.LAB
BE 0707.955.092
Jemeppe-sur-Sambre · Eq €74k
Of 698 companies in sector 86910 we hold annual accounts for 520. 298 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded02-02-2018
Fiscal year end31-12
Activities, NACEBEL
86901Human health activities
86910Medical imaging and medical laboratories
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.